Richmond Pharmacology is excited to join the Gene Therapy Forum 23-25 March 2026 in Boston, USA.

This dedicated forum brings together leaders in gene therapy research, clinical development, biotechnology, regulation, and manufacturing to explore the latest advances in genetic medicine and the translation of innovative therapies into the clinic.

‍

Representing Richmond Pharmacology:

  • Dr Jörg Taubel, Chief Executive Officer

‍

Our Focus at the Forum

  • Advances in gene therapy platforms and delivery technologies
  • Clinical translation strategies for next‑generation genetic medicines
  • Safety, regulatory, and manufacturing considerations
  • Designing early‑phase and first‑in‑human gene therapy trials
  • Strengthening partnerships across academia, biotech, and clinical research

Connect With Us

If you are attending the Gene Therapy Forum 2026 and would like to explore collaboration or development opportunities:

📧 fasteranswers@richmondpharmacology.com

‍

Find out more here: Gene Therapy Forum Conference

‍

Latest news

Richmond Pharmacology Appoints Adam Hurd as Operations Director

August 17, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Adam Hurd as Operations Director
Read more

Upcoming Event

AHA Hypertension Scientific Sessions 2026

07 - 11 October 2026
Richmond Pharmacology is excited to join the AHA Hypertension Scientific Sessions 2026 in Arlington, USA, on 07 – 11 October 2026.
View event